Purax Injection (Predinol Mesylate)

Adult administration

Adults: Inject 2㎎ of pridinol mesylate intramuscularly or intravenously once daily. Adjust the dose as appropriate according to age and symptoms.

This medication may contain glass fragments when opening the injection container, so be careful not to let glass particles enter when cutting the injection container. Particularly caution should be taken when used by children and the elderly. This medication should not be used in certain patients. For example, individuals who are allergic to this medication, those with glaucoma, urinary difficulties due to prostatic hypertrophy, severe heart disease, paralysis of the intestine, those with megacolon, acute pulmonary edema, those with tachycardia, severe arteriosclerosis, and those with narrowed gastrointestinal tract, should not use this medication. Patients with liver or kidney dysfunction should use this medication more cautiously. Using this medication may cause allergic reactions such as rashes or hives, and in rare cases, severe allergic symptoms may appear. If such symptoms occur, discontinue use immediately. Additionally, mental symptoms such as dizziness, staggering, drowsiness, anxiety, and hallucinations may appear, and in such cases, it may be necessary to reduce or discontinue the medication dose. Rarely, symptoms of muscle weakness or inability to sit for long durations may occur. Gastrointestinal symptoms such as dry mouth, nausea, and vomiting may also occur. Skin rashes or erythema may appear, along with eye accommodation disorders or symptoms of glaucoma. This medication may cause drowsiness; therefore, it is advisable to avoid driving a car or operating hazardous machinery while taking it. When used with other medications, interactions may occur, especially when taken with central nervous system depressants or certain antidepressants. Also, some medications may enhance or weaken the effect of this medication when used together. Women who are pregnant or may become pregnant should only use this medication when the therapeutic benefits outweigh the risks. This medication can also be transmitted through breast milk, so nursing mothers are advised not to use it. Safety has not been sufficiently verified for children, so it should only be used when necessary. Elderly individuals may have reduced physical functions, so the drug dose should be decreased or used with caution. This medication is only administered in injection form when oral administration is not feasible, and it is preferable to mix with saline or glucose solution for intravenous injection. When injected alone, the injection speed should be slow, and it is safer to administer it while the patient is lying on their side.

• Rash
• hives
• anaphylactic symptoms
• shock-like symptoms
• dizziness
• staggering
• fainting
• drowsiness
• anxiety
• hallucinations

This medication should be stored in a tightly closed container that blocks light. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius to safely preserve the drug's effectiveness.

Appearance

A brown transparent ampoule containing a colorless transparent liquid

Package unit

1mL X 50 ampoules